Lv1
40 积分 2024-02-22 加入
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
9个月前
已完结
Increased mortality in ankylosing spondylitis is related to disease activity
9个月前
已关闭
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
9个月前
已完结
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
9个月前
已关闭
皖公网安备34019202002308
